Profile | GDS5420 / 235034_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 303.64 | 59 |
GSM1296119 | B_lesional_pre-dose | 270.29 | 57 |
GSM1296076 | C_lesional_pre-dose | 284.77 | 60 |
GSM1296092 | D_lesional_pre-dose | 270.59 | 59 |
GSM1296103 | E_lesional_pre-dose | 446.29 | 66 |
GSM1296078 | F_lesional_pre-dose | 270.08 | 59 |
GSM1296107 | G_lesional_pre-dose | 316.5 | 60 |
GSM1296109 | H_lesional_pre-dose | 330.65 | 60 |
GSM1296080 | I_lesional_pre-dose | 258.83 | 57 |
GSM1296090 | J_lesional_pre-dose | 199.88 | 54 |
GSM1296074 | K_lesional_pre-dose | 256.02 | 58 |
GSM1296111 | L_lesional_pre-dose | 256.26 | 56 |
GSM1296099 | M_lesional_pre-dose | 269.53 | 57 |
GSM1296086 | O_lesional_pre-dose | 281.11 | 59 |
GSM1296117 | P_lesional_pre-dose | 261.73 | 56 |
GSM1296113 | Q_lesional_pre-dose | 271.93 | 56 |
GSM1296096 | R_lesional_pre-dose | 332.71 | 61 |
GSM1296105 | S_lesional_pre-dose | 320.5 | 60 |
GSM1296098 | T_lesional_pre-dose | 370.02 | 62 |
GSM1296101 | U_lesional_pre-dose | 227.43 | 54 |
GSM1296121 | V_lesional_pre-dose | 262.85 | 57 |
GSM1296088 | W_lesional_pre-dose | 250.6 | 57 |
GSM1296082 | X_lesional_pre-dose | 270.83 | 59 |
GSM1296115 | Y_lesional_pre-dose | 284.41 | 58 |
GSM1296084 | Z_lesional_pre-dose | 232.07 | 55 |
GSM1296072 | B_lesional_day8 | 303 | 59 |
GSM1296069 | L_lesional_day8 | 260.48 | 55 |
GSM1296071 | P_lesional_day8 | 231.52 | 53 |
GSM1296070 | Y_lesional_day8 | 348.89 | 61 |
GSM1296073 | V_lesional_day8 | 288.03 | 59 |
GSM1296034 | A_lesional_day15 | 181.51 | 50 |
GSM1296041 | G_lesional_day15 | 258.23 | 56 |
GSM1296035 | R_lesional_day15 | 281.51 | 58 |
GSM1296038 | U_lesional_day15 | 387.04 | 63 |
GSM1296047 | B_lesional_day15 | 246.47 | 55 |
GSM1296039 | E_lesional_day15 | 290.54 | 59 |
GSM1296042 | H_lesional_day15 | 344.77 | 61 |
GSM1296043 | L_lesional_day15 | 350.37 | 61 |
GSM1296037 | M_lesional_day15 | 162.27 | 48 |
GSM1296046 | P_lesional_day15 | 213.52 | 52 |
GSM1296044 | Q_lesional_day15 | 236.95 | 54 |
GSM1296045 | Y_lesional_day15 | 351.93 | 61 |
GSM1296025 | C_lesional_day15 | 157.25 | 49 |
GSM1296033 | D_lesional_day15 | 213.35 | 53 |
GSM1296027 | I_lesional_day15 | 126.71 | 47 |
GSM1296032 | J_lesional_day15 | 185.24 | 51 |
GSM1296024 | K_lesional_day15 | 147 | 48 |
GSM1296031 | W_lesional_day15 | 247.22 | 55 |
GSM1296028 | X_lesional_day15 | 177.04 | 51 |
GSM1296029 | Z_lesional_day15 | 143.38 | 47 |
GSM1296026 | F_lesional_day15 | 224.48 | 55 |
GSM1296030 | O_lesional_day15 | 183.09 | 53 |
GSM1296040 | S_lesional_day15 | 307.63 | 59 |
GSM1296036 | T_lesional_day15 | 307.9 | 58 |
GSM1296048 | V_lesional_day15 | 215.94 | 53 |
GSM1296059 | A_lesional_day43 | 299.73 | 59 |
GSM1296066 | G_lesional_day43 | 252.13 | 55 |
GSM1296060 | R_lesional_day43 | 246.63 | 55 |
GSM1296063 | U_lesional_day43 | 324.41 | 60 |
GSM1296064 | E_lesional_day43 | 303.83 | 60 |
GSM1296067 | H_lesional_day43 | 158.86 | 47 |
GSM1296062 | M_lesional_day43 | 219.81 | 53 |
GSM1296068 | Q_lesional_day43 | 181.69 | 48 |
GSM1296050 | C_lesional_day43 | 184.85 | 51 |
GSM1296057 | D_lesional_day43 | 207.41 | 53 |
GSM1296052 | I_lesional_day43 | 104.51 | 44 |
GSM1296054 | J_lesional_day43 | 160.94 | 48 |
GSM1296049 | K_lesional_day43 | 111.74 | 43 |
GSM1296055 | W_lesional_day43 | 175.24 | 49 |
GSM1296053 | X_lesional_day43 | 139.34 | 47 |
GSM1296058 | Z_lesional_day43 | 304.26 | 59 |
GSM1296051 | F_lesional_day43 | 235.74 | 56 |
GSM1296056 | O_lesional_day43 | 255.67 | 57 |
GSM1296065 | S_lesional_day43 | 404.06 | 64 |
GSM1296061 | T_lesional_day43 | 350.46 | 61 |
GSM1296095 | A_non-lesional_pre-dose | 230.77 | 55 |
GSM1296120 | B_non-lesional_pre-dose | 229.51 | 54 |
GSM1296077 | C_non-lesional_pre-dose | 132.16 | 47 |
GSM1296093 | D_non-lesional_pre-dose | 260.18 | 56 |
GSM1296104 | E_non-lesional_pre-dose | 249.27 | 56 |
GSM1296079 | F_non-lesional_pre-dose | 117.52 | 45 |
GSM1296108 | G_non-lesional_pre-dose | 190.21 | 51 |
GSM1296110 | H_non-lesional_pre-dose | 248.66 | 54 |
GSM1296081 | I_non-lesional_pre-dose | 156.47 | 50 |
GSM1296091 | J_non-lesional_pre-dose | 128.89 | 46 |
GSM1296075 | K_non-lesional_pre-dose | 146.89 | 49 |
GSM1296112 | L_non-lesional_pre-dose | 224.4 | 52 |
GSM1296100 | M_non-lesional_pre-dose | 158.04 | 48 |
GSM1296087 | O_non-lesional_pre-dose | 130.84 | 48 |
GSM1296118 | P_non-lesional_pre-dose | 140.2 | 44 |
GSM1296114 | Q_non-lesional_pre-dose | 166.61 | 47 |
GSM1296097 | R_non-lesional_pre-dose | 193.45 | 52 |
GSM1296106 | S_non-lesional_pre-dose | 192.18 | 51 |
GSM1296102 | U_non-lesional_pre-dose | 163.7 | 48 |
GSM1296122 | V_non-lesional_pre-dose | 140.17 | 45 |
GSM1296089 | W_non-lesional_pre-dose | 318.48 | 59 |
GSM1296083 | X_non-lesional_pre-dose | 170.97 | 50 |
GSM1296116 | Y_non-lesional_pre-dose | 206.83 | 51 |
GSM1296085 | Z_non-lesional_pre-dose | 210.08 | 53 |